Trial Profile
Safety of besifloxacin ophthalmic suspension 0.6% in LASIK surgery patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Besifloxacin (Primary) ; Moxifloxacin
- Indications Infectious conjunctivitis
- Focus Adverse reactions
- 11 Dec 2015 New trial record